Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment. [cell line]

ABSTRACT: The role of MSLN in remodulating tumor microenviroment in high-grade serous ovarian cancer and the underlying mechanisms

ORGANISM(S): Mus musculus

PROVIDER: GSE279819 | GEO | 2025/11/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment.

Project description:The role of MSLN in remodulating tumor microenviroment in high-grade serous ovarian cancer and the underlying mechanisms

2025-11-11 | GSE279226 | GEO

Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment.

Project description:Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment.

| PRJNA1171431 | ENA

Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment. [cell line]

Project description:Knockdown MSLN enhances anti-PD-1 therapy efficacy in high-grade serous ovarian cancer via modulating tumor microenvironment. [cell line]

| PRJNA1174736 | ENA

Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high grade serous ovarian cancer [ATAC-seq]

Project description:Immune therapies have had limited efficacy in high grade serous ovarian cancer (HGSC). The cellular targets and mechanism(s) of action of these agents in HGSC are unknown. Here we performed immune functional and single cell RNA sequencing transcriptional profiling on novel HGSC organoid/immune cell co-cultures treated with a variety of immune checkpoint blockade (ICB) antibodies compared to controls.

2020-11-04 | GSE160750 | GEO

Changes in the tumor microenvironment mark transition from serous borderline tumor to low grade serous carcinoma

Project description:Low grade serous ovarian cancer (LGSC) is a rare subtype of ovarian cancer, characterized by a slow growth rate, resistance to current treatment regimens, multiple recurrences and poor survival. LGSC arise from serous borderline tumor (SBT), however the mechanism of transformation is poorly understood. To better understand the biology of serous ovarian tumors, we performed whole proteome profiling of LGSC, SBT and the more common high grade serous (HGSC) ovarian tumors. Proteins associated with the tumor microenvironment were differentially expressed between LGSC and SBT or HGSC. In particular, fibroblast activation protein (FAP), a protein expressed in cancer associated fibroblasts, is abundantly expressed in LGSC. Furthermore, Tregs and M2 macrophages are more abundant in the stroma of LGSC compared to SBT. Together these data suggest that the tumor microenvironment provides a supportive environment for LGSC tumorigenesis and progression, and that targeting the tumor microenvironment of LGSC may be a viable therapeutic strategy.

2024-08-15 | PXD046360 | Pride

Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high grade serous ovarian cancer [bulk RNA-seq tumor]

2020-11-04 | GSE160751 | GEO

Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high grade serous ovarian cancer [single-cell RNA-seq tumor]

2020-11-04 | GSE160754 | GEO

Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high grade serous ovarian cancer [single-cell RNA-seq organoid]

2020-11-04 | GSE160753 | GEO

Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high grade serous ovarian cancer [bulk RNA-seq immune cells]

2020-11-04 | GSE160752 | GEO

The impact of neoadjuvant chemotherapy on tumor microenvironment in advanced high-grade serous carcinoma

Project description:High-grade serous ovarian, fallopian tube or peritoneal carcinoma is an aggressive subtype that frequently develops resistance to chemotherapy. It remains controversial whether the resistance is caused by the acquisition of new molecular aberrations or alternatively through the selection of rare preexisting tumor clones. To address this question, we applied single cell RNA sequencing to depict the tumor landscape of a single case of advanced high-grade serous fallopian tube carcinoma during neoadjuvant chemotherapy (NACT).

2022-08-16 | GSE191301 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data